Sands Capital Raises $555M Fund for Avenzo’s BioAge Technology
TLDR: Sands Capital has raised a new $555 million life science fund, bringing its total committed capital to $1.3 billion. The fund will focus on investing in therapeutic, diagnostic, and device companies